Indeed, the directionality of this correlation was distinct in triple-negative breast cancer (TNBC) versus HER2-enriched (HER2+) breast cancer, such that TNBCs exhibited a SLX4IPLowTERTHigh expression profile (Fig 5A) as compared with the SLX4IPHigh/TERTLow pattern observed in HER2+ breast cancers (Fig 5B). The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.